RE: This week3 Sep 2018 09:54
'A possible answer might be that a company can only capitalise so much of its expenses, and IQE already undertakes substantial capital investment. Capitalised research and development expenses were £6.4m in the first half of this year, costs that would have pushed the company into losses were they taken through the income statement.
Indeed, the story of IQE is of a company which doesn't produce free cash flow on any sort of regular or bountiful basis, ie has some left over after investments in machinery, facilities, research and those capitalised costs. It raised £95m of cash from a placing in November, leaving it with net cash of £41m at last count.
Substantial investment plans look likely to consume that, and anything else the business produces: another £59m to £82m of capital investment is planned over the next 18 months. In the last year the business generated net cash from its operations of just £20m.'
That's pretty negative. On this basis will they need to do another cashcall at some point?